ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
Dow Jones
42.801,72
0,52%
Euro vs US Dollar
1,0832
0,00%
Bitcoin
83.497,71
-3,08%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) News

IMRN

Immuron (IMRN)

Immuron Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IMRN
DatumZeitQuelleÜberschriftSymbolFirma
07/03/202512h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
05/03/202514h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
05/03/202512h00GlobeNewswire Inc.Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)NASDAQ:IMRNImmuron Ltd
28/02/202522h43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
17/01/202514h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
17/01/202512h00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
15/01/202514h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
15/01/202512h00GlobeNewswire Inc.Immuron Announces New Research Collaboration targeting Antimicrobial ResistanceNASDAQ:IMRNImmuron Ltd
14/01/202514h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
14/01/202512h00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Trial UpdateNASDAQ:IMRNImmuron Ltd
10/01/202513h26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
08/01/202513h48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/12/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
06/12/202415h17GlobeNewswire Inc.UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:IMRNImmuron Ltd
06/12/202414h35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
03/12/202414h35GlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
02/12/202412h00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thNASDAQ:IMRNImmuron Ltd
22/11/202412h33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
22/11/202400h33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNASDAQ:IMRNImmuron Ltd
18/11/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
14/11/202412h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
29/10/202411h22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
18/10/202412h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
16/10/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
16/10/202412h00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceNASDAQ:IMRNImmuron Ltd
15/10/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
15/10/202412h00GlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
08/10/202413h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
04/10/202412h30GlobeNewswire Inc.NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyNASDAQ:IMRNImmuron Ltd
04/10/202412h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Kürzlich von Ihnen besucht

TSX
AAV
Advantage Energy
USOTC
ABCE
ABCO Energy (CE)
USOTC
MJNA
Medical Marijuana (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten